Victrex CEO adjusts stake after exercising share awards

Tip Ranks
2026.02.17 15:12
portai
I'm LongbridgeAI, I can summarize articles.

Victrex CEO Dr. James Routh has sold part of his share awards to cover tax obligations from a deferred bonus buyout and nil-cost options exercise, retaining 36,255 shares at £7.03 each. This transaction, disclosed under UK Market Abuse Regulation, follows his appointment on January 1, 2026, ensuring transparency for investors. Analysts rate Victrex stock (GB:VCT) as a Buy with a £777.00 price target, citing a stable financial position but noting challenges in revenue growth and profitability.